• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Wednesday, November 18, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Oceania Australia New Zealand

Pfizer To Provide Additional 40,000 PAXLOVID Treatment Courses In New Zealand To Help Combat COVID-19

by Theinsightpost
September 14, 2022
in New Zealand
0 0
0
Pfizer To Provide Additional 40,000 PAXLOVID Treatment Courses In New Zealand To Help Combat COVID-19


Tuesday, 13 September 2022, 5:35 am
Press Release: Pfizer

  • Pfizer confirms it will supply an additional
    40,000 PAXLOVID® (nirmatrelvir tablets and ritonavir
    tablets) treatment courses to the New Zealand Government,
    bringing the total to 100,000 PAXLOVID treatment courses in
    New Zealand for 2022.
  • PAXLOVID is the first
    oral treatment of its kind; it is a SARS-CoV-2 main protease
    (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease
    inhibitor) therapy.
  • Data demonstrated up to
    86% relative risk reduction of COVID-19-related
    hospitalisation or death from any cause in adults treated
    with PAXLOVID within five days of symptom onset compared to
    placebo.

AUCKLAND, NEW ZEALAND, 12th
September 2022
– Pfizer announced today that it
will supply the New Zealand Government with an additional
40,000 treatment courses of PAXLOVID® (nirmatrelvir
tablets and ritonavir tablets), bringing a total of 100,000
treatment courses in 2022 for New Zealand. This follows the
initial supply agreement signed in December 2021, and
Medsafe’s provisional consent for the supply and use of
PAXLOVID in New Zealand in March 2022.

Pfizer New
Zealand Managing Director, Anne Harris, said the provision
of this additional supply was an important milestone in the
fight against COVID-19, and a testament to the continued
collaboration between Pfizer and the New Zealand Government
since the beginning of the pandemic.

“Vaccination
remains the most effective way to help prevent COVID-19.
However, we know we need to tackle the virus on many
fronts,” Ms Harris said.

“PAXLOVID provides an
important second line of defence for those most at risk and
can be an important tool in helping Kiwis to stay out of
hospital and avoid serious illness and death.

“This
additional supply means more patients will be able to access
this COVID-19 oral medicine through their healthcare
professional or pharmacy and be treated at home, reducing
the impact on hospitals,” Ms Harris said.

Pfizer New
Zealand Medical Director Dr Krishan Thiru said: “PAXLOVID
is a first-of-its-kind antiviral pill for
COVID-19.

“PAXLOVID works by slowing or
stopping a virus from replicating. This may help reduce
symptoms and the risk of significant health
complications.

“This is why it is important for
people at higher risk, to get tested for COVID-19 at the
first sign of symptoms. That way if they are COVID-19
positive, they can seek medical advice quickly and find out
what treatment may be appropriate for them”, Dr Thiru
said.

PAXLOVID is an oral medicine and should be taken
within the first five days of symptomatic infection. Data
demonstrated up to 86% relative risk reduction of
COVID-19-related hospitalisation or death from any cause in
adults treated with PAXLOVID compared to placebo in those
treated within five days of symptom onset, with no deaths in
the treatment group.

PAXLOVID has provisional consent
for the treatment of coronavirus disease 2019 (COVID-19) in
adults 18 years of age and older, who do not require
initiation of supplemental oxygen due to COVID-19 and are at
increased risk of progression to hospitalisation or
death.

People seeking more information can go to:
treatpositive.co.nz.

Pharmac’s access criteria for
COVID-19 antivirals is available at: COVID-19
antivirals: Access Criteria – Pharmac | New Zealand
Government

About PAXLOVID® (nirmatrelvir
tablets and ritonavir tablets)

PAXLOVID is a
SARS-CoV-2 main protease (Mpro) inhibitor (also known as
SARS-CoV-2 3CL protease inhibitor) therapy. It was developed
to be administered orally so that it can be prescribed early
after infection, potentially helping patients avoid severe
illness (which can lead to hospitalisation and death).
Nirmatrelvir [PF-07321332], which originated in Pfizer
laboratories, is designed to block the activity of the Mpro,
an enzyme that the coronavirus needs to replicate.
Co-administration with a low dose of ritonavir helps slow
the metabolism, or breakdown, of nirmatrelvir in order for
it to remain active in the body for longer periods of time
at higher concentrations to help combat the
virus.

Nirmatrelvir is designed to inhibit viral
replication at a stage known as proteolysis, which occurs
before viral RNA replication. In preclinical studies,
nirmatrelvir did not demonstrate evidence of mutagenic DNA
interactions.

Current variants of concern can be
resistant to treatments that work by binding to the spike
protein found on the surface of the SARS-CoV-2 virus.
PAXLOVID, however, works intracellularly by binding to the
highly conserved Mpro (3CL protease) of the SARS-CoV-2 virus
to inhibit viral replication. Nirmatrelvir has shown
consistent in vitro antiviral activity against the following
variants: Alpha, Beta, Delta, Gamma, Lambda, Mu, and Omicron
BA.1 and BA.2.

PAXLOVID is generally administered at a
dose of 300 mg (two 150 mg tablets) of nirmatrelvir with one
100 mg tablet of ritonavir, given twice-daily for five days.
One carton contains five blister packs of

PAXLOVID, as
co-packaged nirmatrelvir tablets with ritonavir tablets,
providing all required doses for a full five-day treatment
course.

© Scoop Media

Join Scoop Citizen

Scoop is a champion of independent journalism and open publishing – informing New Zealanders through straight-talking independent journalism, and publishing news from a wide range of sectors. Join us and support the publication of trustworthy, relevant, public interest news, freely accessible to all New Zealanders:

Become a member
Find out more

Find more from Pfizer on InfoPages.

 



Source link

ShareTweetSend
Previous Post

Pogba brother held over alleged extortion

Next Post

BARBADOS-FINANCE-Government says debt-for-nature swap necessary

Related News

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD
New Zealand

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD

November 15, 2026
KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact
New Zealand

KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact

November 15, 2026
Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff
New Zealand

Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff

November 14, 2026
Exploring the Paradox: The Dual Nature of Safety Risks in Materials
New Zealand

Exploring the Paradox: The Dual Nature of Safety Risks in Materials

November 14, 2026
Next Post
BARBADOS-FINANCE-Government says debt-for-nature swap necessary

BARBADOS-FINANCE-Government says debt-for-nature swap necessary

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      November 15, 2026
      Government Announces Historic  Billion Investment in Energy Infrastructure Development

      Government Announces Historic $2 Billion Investment in Energy Infrastructure Development

      November 15, 2026
      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      November 15, 2026
      Transform Your Laptop Setup with These 5 Affordable Accessories

      Transform Your Laptop Setup with These 5 Affordable Accessories

      November 15, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy